Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation

The role for hyaluronan (HA) and CD44 in vascular barrier regulation is unknown. We examined high and low molecular weight HA (HMW-HA, ∼1,000 kDa; LMW-HA, ∼2.5 kDa) effects on human transendothelial monolayer electrical resistance (TER). HMW-HA increased TER, whereas LMW-HA induced biphasic TER changes ultimately resulting in EC barrier disruption. HMW-HA induced the association of the CD44s isoform with, and AKT-mediated phosphorylation of, the barrier-promoting sphingosine 1-phosphate receptor (S1P1) within caveolin-enriched lipid raft microdomains, whereas LMW-HA induced brief CD44s association with S1P1 followed by sustained association of the CD44v10 isoform with, and Src and ROCK 1/2-mediated phosphorylation of, the barrier-disrupting S1P3 receptor. HA-induced EC cytoskeletal reorganization and TER alterations were abolished by either disruption of lipid raft formation, CD44 blocking antibody or siRNA-mediated reductions in expression of CD44 isoforms. Silencing S1P1, AKT1, or Rac1 blocked the barrier enhancing effects of HA whereas silencing S1P3, Src, ROCK1/2, or RhoA blocked the barrier disruption induced by LMW-HA. In summary, HA regulates EC barrier function through novel differential CD44 isoform interaction with S1P receptors, S1P receptor transactivation, and RhoA/Rac1 signaling to the EC cytoskeleton.

[1]  S. Dudek,et al.  Regulation of sphingosine 1‐phosphate‐induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and α‐actinin , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Garcia,et al.  Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.

[3]  M. Nguyen,et al.  Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. , 2005, Blood.

[4]  E. Wouters,et al.  Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation , 2005, Thorax.

[5]  D. Cheresh,et al.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis , 2004, The Journal of cell biology.

[6]  S. Salomone,et al.  Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. , 2004, Drug news & perspectives.

[7]  B. Toole,et al.  Hyaluronan: from extracellular glue to pericellular cue , 2004, Nature Reviews Cancer.

[8]  R. Stern,et al.  CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion* , 2004, Journal of Biological Chemistry.

[9]  W. Sessa,et al.  Caveolae and Caveolins in the Cardiovascular System , 2004, Circulation research.

[10]  S. Dudek,et al.  Pulmonary Endothelial Cell Barrier Enhancement by Sphingosine 1-Phosphate , 2004, Journal of Biological Chemistry.

[11]  L. Bourguignon,et al.  CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. , 2004, Experimental cell research.

[12]  G. Turino,et al.  Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema? , 2004, Chest.

[13]  R. Stern.  Devising a pathway for hyaluronan catabolism: are we there yet? , 2003, Glycobiology.

[14]  Richard G. W. Anderson,et al.  Caveolin regulation of endothelial function. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[15]  L. Bourguignon,et al.  Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression* , 2003, Journal of Biological Chemistry.

[16]  M. Pogrel,et al.  Hyaluronan (hyaluronic acid) and its regulation in human saliva by hyaluronidase and its inhibitors. , 2003, Journal of oral science.

[17]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[18]  C. Myers,et al.  Endothelial contraction and monolayer hyperpermeability are regulated by Src kinase. , 2003, American journal of physiology. Heart and circulatory physiology.

[19]  L. Bourguignon,et al.  CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration. , 2002, Cell motility and the cytoskeleton.

[20]  T. Harris,et al.  Reciprocal raft–receptor interactions and the assembly of adhesion complexes , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[21]  M. Slevin,et al.  Angiogenic Oligosaccharides of Hyaluronan Induce Multiple Signaling Pathways Affecting Vascular Endothelial Cell Mitogenic and Wound Healing Responses* , 2002, The Journal of Biological Chemistry.

[22]  S. Klewer,et al.  Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.

[23]  John E. Scott,et al.  Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. , 2002, Biomacromolecules.

[24]  E. Puré,et al.  Resolution of Lung Inflammation by CD44 , 2002, Science.

[25]  M. Tammi,et al.  Hyaluronan and Homeostasis: A Balancing Act* , 2002, The Journal of Biological Chemistry.

[26]  Lilly Y. W. Bourguignon,et al.  Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.

[27]  M. Tammi,et al.  Hyaluronan-Cell Interactions in Cancer and Vascular Disease* , 2002, The Journal of Biological Chemistry.

[28]  A. Csoka,et al.  The six hyaluronidase-like genes in the human and mouse genomes. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[29]  S. Dudek,et al.  Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.

[30]  S. Santavirta,et al.  Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses , 2001, The Journal of pathology.

[31]  L. Bourguignon,et al.  CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration* , 2001, The Journal of Biological Chemistry.

[32]  S. Pyne,et al.  Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. , 2000, Pharmacology & therapeutics.

[33]  S. Klewer,et al.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.

[34]  R. Midura,et al.  Adaptation of FACE methodology for microanalysis of total hyaluronan and chondroitin sulfate composition from cartilage. , 2000, Glycobiology.

[35]  H. Schwarz,et al.  Analysis of Cd44-Containing Lipid Rafts , 1999, The Journal of cell biology.

[36]  W. Kiosses,et al.  Regulation of the small GTP‐binding protein Rho by cell adhesion and the cytoskeleton , 1999, The EMBO journal.

[37]  L. Bourguignon,et al.  CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. , 1998, Frontiers in bioscience : a journal and virtual library.

[38]  M. Mohamadzadeh,et al.  Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. , 1998, The Journal of clinical investigation.

[39]  P. Heldin,et al.  Mechanism of impaired local hyaluronan turnover in bleomycin-induced lung injury in rat. , 1997, American journal of respiratory cell and molecular biology.

[40]  K. Simons,et al.  Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. , 1997, Current opinion in cell biology.

[41]  J. Hogg,et al.  Proteoglycan deposition in pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.

[42]  N Iida,et al.  The Cell Adhesion Molecule, GP116, Is a New CD44 Variant (ex14/v10) Involved in Hyaluronic Acid Binding and Endothelial Cell Proliferation* , 1996, The Journal of Biological Chemistry.

[43]  J. Bell,et al.  CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. , 1994, International immunology.

[44]  J. Pearson.  Endothelial cell biology. , 1991, Radiology.

[45]  R. Hällgren,et al.  Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. , 1989, The American review of respiratory disease.

[46]  M. Cowman,et al.  Combined alcian blue and silver staining of glycosaminoglycans in polyacrylamide gels: application to electrophoretic analysis of molecular weight distribution. , 1986, Analytical biochemistry.